LONDON & NEW YORK, June 23, 2025--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the successful ...

While Amgen’s monthly obesity candidate MariTide helped patients lose significant amounts of weight in a phase 2 study, prevalent gastrointestinal side effects are leading the company to use a ...

Three Phase Sectionalizer Market to Reach $1.9 Billion by 2034, Driven by Grid Modernization ⚡🌍 Three phase sectionalizer market ...

An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a phase 3 assessment next year to see if it could offer a ...

Pathbreakers Season 3 Sneak Peek: Pramath Sinha on the future of jobs and education in the age of AI When machines learn faster than humans, how should education evolve?

Exelixis, Inc. (Nasdaq: EXEL) today announced positive topline results from the STELLAR-303 phase 3 pivotal trial in which zanzalintinib in combination with ...

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial.

This article proposes a fault-tolerant field-oriented control strategy for five-phase surface-mounted permanent magnet synchronous machine with non-sinusoidal back electromotive force under ...

This paper proposes a method to diagnose the open-circuit faulty phases and faulty points of the six-phase permanent magnet synchronous motor (PMSM) drive circuit.

“We are excited to advance VK2735 into Phase 3 clinical development, moving one step closer to potentially bringing this important therapeutic to patients with obesity,” said Brian Lian, Ph.D., chief ...

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL between May 30 th and June 3 rd, 2025, was host to a prostate, testicular, and penile cancers ...